OliX Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

OliX Pharmaceuticals, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OLIX.

1014, 17, Daehak 4-ro,

Yeongtong-gu, Suwon-si Gyeonggi-do

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OLIX
OLIX
Registered 2021

Trademark Classifications

OliX Pharmaceuticals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does OliX Pharmaceuticals, Inc. have?

OliX Pharmaceuticals, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does OliX Pharmaceuticals, Inc. file in?

OliX Pharmaceuticals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are OliX Pharmaceuticals, Inc.'s most well-known trademarks?

OliX Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as OLIX. These are among 1 currently registered trademark in the portfolio.

What is OliX Pharmaceuticals, Inc.'s trademark registration success rate?

OliX Pharmaceuticals, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.